Clinical Trial: CYP2D6 Related Dose Escalation of Tamoxifen in Breast Cancer Patients With Iranian Ethnic Background Resulted in Increased Concentrations of Tamoxifen and Its Metab...

by Zahra Khalaj, Zohreh Baratieh, Parvaneh Nikpour, Parvaneh Nikpour, Matthias Schwab, Matthias Schwab, Matthias Schwab, Elke Schaeffeler, Elke Schaeffeler, Fariborz Mokarian, Hossein Khanahmad, Rasoul Salehi, Rasoul Salehi, Thomas E. Mürdter, Thomas E. Mürdter, Mansoor Salehi, Mansoor Salehi, Mansoor Salehi
Published 2019-05-01

Metabolic Drug Response Phenotyping in Colorectal Cancer Organoids by LC-QTOF-MS

by Sylvia K. Neef, Nicole Janssen, Stefan Winter, Svenja K. Wallisch, Ute Hofmann, Marc H. Dahlke, Matthias Schwab, Thomas E. Mürdter, Mathias Haag
Published 2020-12-01

Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing Strategies

by Anna Mueller-Schoell, Lena Klopp-Schulze, Robin Michelet, Madelé van Dyk, Thomas E. Mürdter, Matthias Schwab, Markus Joerger, Wilhelm Huisinga, Gerd Mikus, Charlotte Kloft
Published 2021-02-01

Computational Treatment Simulations to Assess the Need for Personalized Tamoxifen Dosing in Breast Cancer Patients of Different Biogeographical Groups

by Anna Mueller-Schoell, Robin Michelet, Lena Klopp-Schulze, Madelé van Dyk, Thomas E. Mürdter, Matthias Schwab, Markus Joerger, Wilhelm Huisinga, Gerd Mikus, Charlotte Kloft
Published 2021-05-01